BalinBac Therapeutics, Inc.

Microbiome Therapeutics Company with Products to Cure Irritable Bowel Syndrome and Gastrointestinal Infectious Diseases.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Princeton, NJ, USA
  • Currency USD
  • Founded January 2014
  • Employees 4
  • Incorporation Type S-corp
  • Website balinbac.com

Company Summary

BalinBac Therapeutics, Inc., is a life science microbiome focused operating company pioneering the development of breakthrough products in gastro-intestinal disease, infectious disease, immuno-oncology, and animal nutrition.

BalinBac is focused on rapidly developing its proven and highly de-risked key antibiotic, BB-100 for curing constipation predominant irritable bowel syndrome.
BB-100 will cure some of the most deadly GI infections.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free